OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
Published in:
2016
By:
- Kavanaugh, Arthur;
- Mclnnes, Iain B.;
- Mease, Philip J.;
- Hall, Stephen;
- Chinoy, Hector;
- Kivitz, Alan J.;
- Zailong Wang;
- Mpofu, Shephard;
- McInnes, Iain B;
- Wang, Zailong
Publication type:
journal article
Modeling and Analysis of Multi-Library, Multi-Group SAGE Data with Application to a Study of Mouse Cerebellum.
Published in:
Biometrics, 2007, v. 63, n. 3, p. 777, doi. 10.1111/j.1541-0420.2006.00733.x
By:
- Wang, Zailong;
- Lin, Shili;
- Popesco, Magdalena;
- Rotter, Andrej
Publication type:
Article
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Published in:
Arthritis Care & Research, 2017, v. 69, n. 3, p. 347, doi. 10.1002/acr.23111
By:
- Kavanaugh, Arthur;
- Mease, Philip J.;
- Reimold, Andreas M.;
- Tahir, Hasan;
- Rech, Jürgen;
- Hall, Stephen;
- Geusens, Piet;
- Wang, Zailong;
- Pricop, Luminita;
- Mpofu, Shephard
Publication type:
Article
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Published in:
2016
By:
- Kavanaugh, Arthur;
- Mease, Philip J;
- Reimold, Andreas M;
- Tahir, Hasan;
- Rech, Jürgen;
- Hall, Stephen;
- Geusens, Piet;
- Wang, Zailong;
- Pricop, Luminita;
- Mpofu, Shephard;
- FUTURE-1 Study Group
Publication type:
journal article
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
Published in:
Rheumatology, 2023, v. 62, n. 6, p. 2122, doi. 10.1093/rheumatology/keac605
By:
- Östör, Andrew;
- Bosch, Filip Van den;
- Papp, Kim;
- Asnal, Cecilia;
- Blanco, Ricardo;
- Aelion, Jacob;
- Lu, Wenjing;
- Wang, Zailong;
- Soliman, Ahmed M;
- Eldred, Ann;
- Padilla, Byron;
- Kivitz, Alan
Publication type:
Article
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
Published in:
Clinical Transplantation, 2013, v. 27, n. 2, p. 217, doi. 10.1111/ctr.12045
By:
- Shihab, Fuad S.;
- Cibrik, Diane;
- Chan, Laurence;
- Kim, Yu Seun;
- Carmellini, Mario;
- Walker, Rowan;
- Zibari, Gazi;
- Pattison, James;
- Cornu‐Artis, Catherine;
- Wang, Zailong;
- Tedesco‐Silva Jr, Helio
Publication type:
Article
ELEVATE: an innovative study design to assess the efficacy, safety, and evolution of cardiovascular parameters in de novo kidney transplant recipients after early conversion from a calcineurin inhibitor to everolimus.
Published in:
Open Access Journal of Clinical Trials, 2014, v. 6, p. 17, doi. 10.2147/OAJCT.S59549
By:
- van der Giet, Markus;
- Cruzado, Josep M.;
- de Fijter, Johan W.;
- Holdaas, Hallvard;
- Zailong Wang;
- Speziale, Antonio;
- Junge, Guido
Publication type:
Article
Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial.
Published in:
Journal of Nephrology (JNonline), 2015, v. 28, n. 5, p. 633, doi. 10.1007/s40620-015-0180-6
By:
- Carmellini, Mario;
- Garcia, Valter;
- Wang, Zailong;
- Vergara, Marcela;
- Russ, Graeme
Publication type:
Article

Found: 8